• Oral HT associated with risk for VTE

    5 monthes ago - By Healio

    British women recently exposed to oral hormone therapy were 58% more likely to receive a primary diagnosis of venous thromboembolism than women not exposed to HT, with risk increasing for certain combined preparations, according to findings published in The BMJ.
    “Our study has shown that, for oral treatments, different tablets are associated with different risks of developing blood clots, depending on the active components,” Yana Vinogradova, PhD, a research fellow in medical statistics at the University of Nottingham, U.K., said in a press release. “It has also confirmed
    Read more ...

     

  • Oral HRT for Menopause Has Highest VTE Risk, Dermal Route Safest

    5 monthes ago - By Medscape

    Women taking HRT for menopausal symptoms should be counseled to use transdermal preparations over oral ones to reduce their venous thromboembolism risk, conclude UK experts following large study.
    Medscape Medical News
    Read more ...